JPWO2022114111A1 - - Google Patents

Info

Publication number
JPWO2022114111A1
JPWO2022114111A1 JP2022565438A JP2022565438A JPWO2022114111A1 JP WO2022114111 A1 JPWO2022114111 A1 JP WO2022114111A1 JP 2022565438 A JP2022565438 A JP 2022565438A JP 2022565438 A JP2022565438 A JP 2022565438A JP WO2022114111 A1 JPWO2022114111 A1 JP WO2022114111A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565438A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022114111A1 publication Critical patent/JPWO2022114111A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
JP2022565438A 2020-11-27 2021-11-26 Pending JPWO2022114111A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020196449 2020-11-27
PCT/JP2021/043348 WO2022114111A1 (ja) 2020-11-27 2021-11-26 医薬品又は化粧品用組成物

Publications (1)

Publication Number Publication Date
JPWO2022114111A1 true JPWO2022114111A1 (es) 2022-06-02

Family

ID=81755618

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565438A Pending JPWO2022114111A1 (es) 2020-11-27 2021-11-26

Country Status (2)

Country Link
JP (1) JPWO2022114111A1 (es)
WO (1) WO2022114111A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024050599A1 (en) * 2022-09-06 2024-03-14 Paradigm Biopharmaceuticals Ltd Treatment of psoriasis, psoriatic arthritis and dermatitis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2540691B2 (ja) * 1992-04-30 1996-10-09 古河機械金属株式会社 痛み治療剤
WO1994008574A1 (en) * 1992-10-13 1994-04-28 Otsuka America Pharmaceutical, Inc. Treatment of cachexia and inhibition of il-6 activity
JP4063868B2 (ja) * 1995-02-28 2008-03-19 ザ ジレット カンパニー 毛髪成長を抑制するための脈管形成抑制剤の使用
AU2004209428A1 (en) * 2003-01-31 2004-08-19 Jessie L.-S. Au Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
JP4978015B2 (ja) * 2005-02-01 2012-07-18 味の素株式会社 血行促進外用剤及びこれを含有してなる皮膚毛髪用化粧料及び入浴剤
JP5464778B2 (ja) * 2006-03-10 2014-04-09 花王株式会社 頭髪化粧料
JP2009221136A (ja) * 2008-03-14 2009-10-01 Tatsuo Kaneko 糖誘導体製剤
EP3556850A1 (en) * 2012-12-12 2019-10-23 Mesoblast, Inc. Treatment of diseases of endothelial dysfunction and inflammation
EP3632451A4 (en) * 2017-05-31 2021-03-10 Oji Holdings Corporation TOPICAL MOISTURIZING PREPARATION
MX2020006605A (es) * 2017-12-20 2020-09-10 Oji Holdings Corp Polisulfato de pentosano y medicamento que contiene polisulfato de pentosano.
TW201940178A (zh) * 2018-01-31 2019-10-16 日商瑪路弘股份有限公司 皮膚外用組成物
WO2019151285A1 (ja) * 2018-01-31 2019-08-08 マルホ株式会社 皮膚外用組成物
WO2019151287A1 (ja) * 2018-01-31 2019-08-08 マルホ株式会社 皮膚外用組成物

Also Published As

Publication number Publication date
WO2022114111A1 (ja) 2022-06-02

Similar Documents

Publication Publication Date Title
BR112023005462A2 (es)
BR112021014123A2 (es)
BR112023012656A2 (es)
BR112022024743A2 (es)
JPWO2022114111A1 (es)
BR112022009896A2 (es)
BR102021007058A2 (es)
BR102020022030A2 (es)
BR112023011738A2 (es)
BR112023016292A2 (es)
BR112023004146A2 (es)
BR112023011610A2 (es)
BR112023011539A2 (es)
BR112023008976A2 (es)
BR112023009656A2 (es)
BR112023006729A2 (es)
BR102021016375A2 (es)
BR102021015450A8 (es)
BR102021014044A2 (es)
BR102021014056A2 (es)
BR102021013929A2 (es)
BR112021017747A2 (es)
BR102021012571A2 (es)
BR102021012230A2 (es)
BR102021012107A2 (es)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230810